कंपनी का अवलोकन
Waldencast plc operates within the consumer defensive sector, specifically focusing on the household and personal products industry, where it provides essential beauty and wellness solutions to consumers globally. The company's business model centers on two primary segments, Obagi Medical and Milk Makeup, offering a wide array of skin care products designed to minimize signs of skin aging, address hyperpigmentation, and treat various dermatological concerns across the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. With a market capitalization of $141.09M and an annual revenue of $272.07M, Waldencast maintains a modest scale supported by a workforce of 367 employees. These valuation and revenue figures indicate that the company functions as a small-cap entity with limited market dominance, suggesting its position as a niche player rather than a dominant force in the broader beauty industry landscape.
वित्तीय स्वास्थ्य
The company reported a total revenue of $272.07M over the trailing twelve months, yet simultaneously recorded a net income loss of $229,748,992 and an EBITDA of $-5,782,000. The substantial gap between the positive revenue figure and the negative net income reveals a highly volatile cost structure where operating expenses or impairment charges significantly erode profitability, resulting in a profit margin of -84.4%. Despite the operating losses, the company generated a positive free cash flow of $115.17M, which provides a degree of financial flexibility by indicating that operational cash generation exceeds capital expenditures and working capital requirements. This positive cash flow contrasts sharply with the negative operating margin of -22.5% and the even more severe profit margin, highlighting a divergence between accounting profitability and actual cash liquidity. The balance sheet shows a cash holding of $30.38M against total debt of $149.01M, creating a net debt position, while the debt-to-equity ratio stands at 29.80, indicating a leveraged balance sheet structure. However, the current ratio of 1.70 suggests that the company possesses adequate short-term liquid assets to cover its current liabilities without immediate distress. The return on equity is -40.3% and the return on assets is -4.7%, metrics that reveal management has yet to generate returns on shareholder capital or total assets, pointing to ongoing operational challenges or significant one-time costs impacting effectiveness.
मूल्यांकन आकलन
The trailing twelve-month P/E ratio is listed as N/A due to the absence of net income, while the forward P/E ratio is calculated at -2.16. The negative forward P/E implies that the market is pricing in continued losses or significant earnings volatility, making traditional earnings-based valuation metrics difficult to apply effectively in the short term. The price-to-book ratio is 0.28, which indicates that the company is trading at a significant discount to its book value, suggesting the market values its assets at less than the accounting book value, potentially due to poor future earnings prospects or industry-specific risks. Alternative valuation metrics such as the price-to-sales ratio of 0.52 and the EV/EBITDA of -49.62 further suggest that investors are valuing the company based on revenue multiples rather than profitability, as the negative EV/EBITDA reflects the underlying losses. Regarding price metrics, the 52-week high is $3.22 and the 52-week low is $0.86; without a specific current price provided in the facts, the valuation context relies entirely on these historical trading bounds which define the extreme volatility range for the stock. The beta value is -0.07, a unique metric that suggests the stock price moves inversely to the broader market or exhibits negligible correlation, indicating extreme idiosyncratic risk rather than standard market beta exposure.
Growth & Income
The company experienced a revenue growth rate of -1.7% year-over-year, while the earnings growth rate is N/A due to the lack of comparable prior earnings data. The decline in revenue combined with the absence of positive earnings growth implies that the business is currently contracting rather than expanding, which challenges the typical growth narrative for companies in the consumer defensive sector. As a non-dividend payer, Waldencast reports a dividend yield of N/A and a payout ratio of 0.0%, meaning the company does not distribute cash to shareholders and instead retains any available cash flow for internal use or debt reduction. The overall growth and income profile for Waldencast is characterized by negative revenue expansion, no earnings distribution, and a reliance on cash flow generation rather than profitability to sustain operations and fund future initiatives.